Cellexus
Private Company
Total funding raised: $750K
Overview
Cellexus is a private biotechnology equipment company founded in 2015 and headquartered in Cambridge, UK, specializing in innovative single-use airlift bioreactors. Its core technology, the CellMaker system, offers a unique method of aeration and mixing aimed at improving cell growth, yield, and process simplicity while reducing contamination risk. The company serves the cell therapy and biologics sectors, providing equipment and custom solutions from early-stage research to scale-up, and is in a revenue-generating stage with a direct sales and support business model.
Technology Platform
Single-use airlift bioreactor systems (CellMaker) for gentle, low-shear mixing and aeration in cell culture and fermentation processes.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes against major players in single-use bioreactors like Sartorius, Thermo Fisher Scientific, Cytiva (Danaher), and Merck Millipore, which primarily offer stirred-tank systems. Cellexus differentiates through its airlift technology, emphasizing low-shear mixing, simplicity, and reduced contamination risk for specific sensitive cell culture applications.